Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Smith & Nephew Snats ( (SNN) ) has shared an update.
Smith & Nephew plc, a company known for its medical devices and healthcare solutions, announced a final dividend of 23.1 US cents per ordinary share for the year ending December 31, 2024. This dividend will be paid on May 28, 2025, to shareholders registered as of March 28, 2025. UK-based shareholders or those who opted for sterling dividends will receive 17.48 pence per share.
The most recent analyst rating on (SNN) stock is a Hold with a $27.27 price target. To see the full list of analyst forecasts on Smith & Nephew Snats stock, see the SNN Stock Forecast page.
Spark’s Take on SNN Stock
According to Spark, TipRanks’ AI Analyst, SNN is a Outperform.
Smith & Nephew Snats receives a solid overall score of 77.0, driven by strong financial performance and positive earnings call sentiment. The company’s impressive revenue and profit growth, coupled with innovation-driven strategies, contribute to a favorable outlook. However, high valuation ratios and technical analysis indicators suggest caution. Challenges in the China market and input cost pressures in Orthopedics remain key risks.
To see Spark’s full report on SNN stock, click here.
More about Smith & Nephew Snats
Average Trading Volume: 899,806
Technical Sentiment Signal: Buy
Current Market Cap: $12.58B
Learn more about SNN stock on TipRanks’ Stock Analysis page.